CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586

11 May 2023 06:30:00 By Nasdaq GlobeNewswire

Cytokinetics to Participate in the JMP Securities Life Sciences Conference

08 May 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Reports First Quarter 2023 Financial Results

04 May 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Hold Annual Meeting of Stockholders

03 May 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 May 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Announce First Quarter Results on May 4, 2023

20 Apr 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference

10 Apr 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Apr 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis

31 Mar 2023 06:30:00 By Nasdaq GlobeNewswire

Cytokinetics Releases Inaugural Corporate Responsibility Report

27 Mar 2023 06:30:00 By Nasdaq GlobeNewswire

Cytokinetics to Participate in Upcoming Investor Conferences

06 Mar 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session

04 Mar 2023 09:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Mar 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Reports Fourth Quarter 2022 Financial Results

01 Mar 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Receives Complete Response Letter From FDA for New Drug Application for Omecamtiv Mecarbil

28 Feb 2023 16:31:51 By Nasdaq GlobeNewswire

Cytokinetics Announces Three Upcoming Presentations at the American College of Cardiology 72nd Annual Scientific Session

24 Feb 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

22 Feb 2023 06:30:00 By Nasdaq GlobeNewswire

Cytokinetics to Announce Fourth Quarter Results on March 1, 2023

15 Feb 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Feb 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program

30 Jan 2023 06:30:00 By Nasdaq GlobeNewswire